Walking as a viable alternative to moderate-to-vigorous physical activity for improving cardiovascular outcomes in coronary artery disease patients
Zejun Yang(Capital Medical University), Changsheng Ma(Second Hospital of Shandong University), Xiaodong Peng(Capital Medical University), Caihua Sang(Capital Medical University), Xin Du(Shenzhen Second People's Hospital), Jianzeng Dong(First Affiliated Hospital of Zhengzhou University), Ning Zhou(Tongji Hospital), Weihua Zhang(Shandong Academy of Agricultural Sciences), Cong Yuan(The First Hospital of Changsha), Xiaoxia Liu(Capital Medical University), He Liu(Capital Medical University), Yiwei Lai(Capital Medical University), Le Zhou(Yangzhou University), Yunting Liang(Beijing Anzhen Hospital)
International Journal of Cardiology Cardiovascular Risk and Prevention
June 9, 2025
Cited by 0
Related Papers
Large-scale association analysis identifies new risk loci for coronary artery disease
|Nature Genetics|2012|1.7k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
|Nature Genetics|2018|476
Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults
|PLoS Genetics|2017|345